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Is rate–pressure product of any use in the isolated rat
heart? Assessing cardiac ‘effort’ and oxygen consumption
in the Langendorff-perfused heart
Dunja Aksentijević, Hannah R. Lewis and Michael J. Shattock
British Heart Foundation Centre of Research Excellence, King’s College London, The Rayne Institute, St Thomas’ Hospital, London, UK
New Findings
 What is the central question of this study?
Rate–pressure product (RPP) is commonly used as an index of cardiac ‘effort’. In canine and
human hearts (which have a positive force–frequency relationship), RPP is linearly correlated
with oxygen consumption and has therefore been widely adopted as a species-independent
index of cardiac work. However, given that isolated rodent hearts demonstrate a negative
force–frequency relationship, its use in this model requires validation.
 What is the main finding and its importance?
Despite its widespread use, RPP is not correlated with oxygen consumption (or cardiac ‘effort’)
in the Langendorff-perfused isolated rat heart. This lack of correlation was also evident when
perfusions included a range of metabolic substrates, insulin or β-adrenoceptor stimulation.
Langendorff perfusion of hearts isolated from rats and mice has been used extensively
for physiological, pharmacological and biochemical studies. The ability to phenotype these
hearts reliably is, therefore, essential. One of the commonly used indices of function is
rate–pressure product (RPP); a rather ill-defined index of ‘work’ or, more correctly, ‘effort’.
Rate–pressure product, as originally described in dog or human hearts, was shown to be
correlated with myocardial oxygen consumption (MV̇O2 ). Despite its widespread use, the
application of this index to rat or mouse hearts (which, unlike the dog or human, have
a negative force–frequency relationship) has not been characterized. The aim of this study
was to examine the relationship between RPP and MV̇O2 in Langendorff-perfused rat hearts.
Paced hearts (300–750 beats min−1) were perfused either with Krebs–Henseleit (KH) buffer
(11 mm glucose) or with buffer supplemented with metabolic substrates and insulin. The
arteriovenous oxygen consumption (MV̇O2 ) was recorded. Metabolic status was assessed using
31P magnetic resonance spectroscopy and lactate efflux. Experiments were repeated in the
presence of isoprenaline and in unpaced hearts where heart rate was increased by cumulative
isoprenaline challenge. In KH buffer-perfused hearts, MV̇O2 increased with increasing heart
rate, but given that left ventricular developed pressure decreased with increases in rate, RPP
was not correlated with MV̇O2 , lactate production or phosphocreatine/ATP ratio. Although the
provision of substrates or β-adrenoceptor stimulation changed the shape of the RPP–MV̇O2
relationship, neither intervention resulted in a positive correlation between RPP and oxygen
consumption. Rate–pressure product is therefore an unreliable index of oxygen consumption
or ‘cardiac effort’ in the isolated rat heart.
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Introduction
Langendorff perfusion of hearts isolated from rats
and mice has been used extensively for physiological,
pharmacological, biochemical and molecular studies for
many years. The ability to modify mice genetically has
further enhanced the utility of this technique and the
ability to phenotype these hearts reliably has become
essential. One of the commonly used indices of function is
rate–pressure product (RPP), which is frequently adopted
as some rather ill-defined index of ‘work’ or, more
correctly, ‘effort’. Rate–pressure product was originally
described by Katz & Feinberg (1958) as an index of ‘cardiac
effort’ in dog hearts and shown to be linearly correlated
with oxygen consumption. This correlation with oxygen
consumption was confirmed in human hearts by Kitamura
et al. (1972). However, despite its widespread use, the
application of this index to rat and mouse hearts, has
a problem; namely, whereas dogs, humans and most
other large mammals show a positive force–frequency
relationship (FFR) (Bers, 2000) (that is, as heart rate
increases so does force development), this relationship is
flat or even negative in the electrically paced isolated rat
or mouse heart (Sutherland et al. 2003). Thus, although
RPP may increase with heart rate and be correlated with
myocardial O2 consumption (MV̇O2 ) in the human heart,
what happens in the isolated rat or mouse heart has never
been defined.
This relationship is further complicated by the fact that
the heart in vivo rarely, if ever, encounters a substantial
rise in heart rate without β-adrenoceptors being occupied.
Despite this, many studies use electrical pacing to elevate
rate in the absence of β-agonists (Sutherland et al. 2003).
β-Adrenergic stimulation will phosphorylate key players
in the pathway of excitation–contraction coupling, such as
L-type Ca2+ channels, phospholamban, phospholemman,
troponin I and the ryanodine receptor; changes that will
modulate contractility and hence oxygen consumption
(Lindemann et al. 1983; Vassallo et al. 1994; Bers, 2000;
Shattock, 2009). In this context, β-adrenergic stimulation
has been shown to transform the negative force–frequency
relationship in the isolated mouse heart into a positive one
(Kennington, 2009).
Not only does the isolated heart usually lack adrenergic
tone, but it is frequently provided with only glucose (and
no insulin) as a metabolic substrate. The lack of the normal
range of substrate provision is again likely to influence
the relationship between metabolic efficiency, myocardial
oxygen consumption and contractility, particularly when
heart rate is elevated.
The aim of this study was to examine the relation-
ship between RPP and MV̇O2 in the isolated Langendorff-
perfused rat heart and, in keeping with its original
definition, to establish whether RPP is an appropriate
index of cardiac effort. In order to mimic the effect of
physiological conditions on the investigated RPP–MV̇O2
relationship, in addition to experiments with the
most commonly used crystalloid hyperglycaemic
Krebs–Henseleit (KH) buffer, perfusions were carried out
with KH buffer containing physiological concentrations




All experiments were approved by the institutional ethical
review committee and conform to the UK Animals
(Scientific Procedures) Act 1986 incorporating European
Directive 2010/63/EU.
Animals
Male Wistar rats (316 ± 58 g body weight, n = 36)
were purchased from Harlan Laboratories (UK). Rats were
housed in pathogen-free cages with a 12 h–12 h light–dark
cycle, controlled humidity and temperature (20–22°C)
and fed standard rat chow and water ad libitum.
Isolated heart perfusion
Rats were anaesthetized by I.P. injection of 0.9 ml
sodium pentobarbitone 20% w/v (Pentoject, Animalcare
Ltd., York, UK). Hearts (wet weight 1.31 ± 0.23 g,
n = 36) were rapidly excised and arrested in ice-cold
KH buffer. The aorta was cannulated and secured with
sutures (Mersilk 3-0; Ethicon, Somerville, NJ, USA).
Hearts were perfused at a constant perfusion pressure of
80 ± 2 mmHg using a peristaltic pump (Gilson Minipuls
4, Middleton, WI, USA) and a feedback control system
(STH Pump Controller; AD Instruments, Oxford, UK).
Buffer was equilibrated with 95% O2–5% CO2 using
a custom-made counter-current membrane oxygenator
consisting of spirally wound Silastic tubing (1.47 mm
i.d., 1.96 mm o.d.; VWR International, Lutterworth, UK)
continually flushed with gas at 37°C. A fluid-filled balloon,
attached to a pressure transducer, was inserted into the
left ventricle and inflated to give an end-diastolic pressure
between 3 and 8 mmHg. Left ventricular pressure (LVP),
perfusion pressure, coronary flow and arterial and venous
oxygen tensions were recorded using a PowerLab recorder
and LabChart 7.0 software (ADInstruments). Functional
parameters were averaged for 80 cardiac cycles at 5 min
intervals.
Left ventricular developed pressure (LVDP) was
calculated as the difference between maximal systolic
(SP) and end-diastolic pressures. Rate–pressure product
was defined as the product of heart rate (HR) and
left ventricular developed pressure: RPP = (HR ×
LVDP)/1000.
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Venous effluent samples, taken during equilibration and
within the last minute of each frequency increase, were
immediately frozen in liquid nitrogen and stored at −80°C
for analysis of lactate concentration. Samples were then
thawed on ice before analysis in triplicate with a YSI 2300
Stat Plus Lactate Analyser (YSI Life Sciences, Tunbridge
Wells, UK).
Myocardial oxygen consumption
Arterial and venous oxygen was measured using two
420-μm-diameter fibre-optic oxygen sensors (Ocean
Optics, NeoFox, UK) calibrated prior to use with 0% O2
(using the reducing agent 4% w/v sodium hydrosulphite)
and 100% O2 gassed water. One probe was placed in
the aortic inflow arterial line and the second, venous
probe was placed in the right ventricular outflow tract
inserted via the pulmonary artery. The oxygen content of
arterial and venous perfusate was recorded as percentage
O2 saturation. Atmospheric pressure (in millimetres
of mercury) was measured daily, and MV̇O2 was then
calculated according to the following equation:






in micromoles per minute per gram dry weight
Where PB is atmospheric pressure (in millimetres of
mercury), %O2 is the arteriovenous difference in
percentage O2 saturation, SO2 is the solubility of
oxygen in Krebs-Henseleit (KH) buffer = 1.22 ×
10−3 μmol ml−1 mmHg−1 at BTSP (Chemnitius et al.
1985; Schenkman et al. 2003), CF is coronary flow (in
millilitres per minute) and Dry Wt is the dry weight of the
heart (in grams).
Perfusion solutions
Krebs–Henseleit buffer. The standard KH buffer
contained (mM): 118 NaCl, 25 NaHCO3, 4.8 KCl, 1.2
KH2PO4, 1.2 MgSO4.7H2O, 1.4 CaCl2.7H2O and 11
glucose, pH 7.4.
Substrate-enriched metabolic (KHmetab) buffer. In some
experiments, the glucose concentration of the KH buffer
was 5 mmol l−1 and the additional substrates and
compounds included the following (mM): 1 sodium
L-lactate, 0.1 sodium pyruvate, 0.5 L-glutamic acid
monosodium salt monohydrate; 5 mU l−1 insulin
(NovoRapid insulin; Novo Nordisk, Denmark) and 0.3
sodium palmitate with 3% (w/v) bovine serum albumin
(BSA; Proliant Biologicals, Ankeny, IA, USA; Smith et al.
2010). Prior to inclusion, BSA was prepared as follows.
Purification of BSA. Bovine serum albumin was dissolved
(30% w/v) in a solution containing (mM): 118 NaCl
and 2.5 CaCl2.7H2O. Visking dialysis tubing (Medicell
Membranes Ltd., London, UK) was prepared by boiling
for 10 min in a solution containing (mM): 1 EDTA, 119
NaHCO3, rinsed with ddH2O and then boiled for another
10 min in 1 mmol l−1 EDTA. The tubing was given a final
rinse in ddH2O before the BSA solution was transferred
and left to dialyse for 48 h at 4°C against a 20-fold larger
volume of (mM): 118 NaCl and 2.5 CaCl2.7H2O. This
removed molecular impurities (molecular mass cut-off of
12–14 kDa) and saturated the Ca2+-binding sites of BSA
(Smith et al. 2010).
All buffers were filtered through a 5.0 μm cellulose
nitrate membrane filter (Whatman, Maidstone, UK).
Appropriate corrections were made for Na+ and Ca2+
concentrations in the KH buffer to account for their
presence in BSA solution stock (Smith et al. 2010).
Perfusion protocols
Hearts were paced via epicardial silver wire electrodes
placed at the apex of the left ventricle and the right
atrium. After a 20 min functional equilibration period and
continuous pacing at 300 beats min−1, the frequency of
the pacing was increased every 5 min in 1 Hz increments up
to 720 beats min−1. Hearts were divided into the following
five groups: (i) crystalloid perfusion (KH buffer);
(ii) perfusion using the substrate-enriched KHmetab
buffer; (iii) crystalloid perfusion plus β-adrenergic
receptor stimulation with isoprenaline hydrochloride
(10 nM); (iv) KHmetab buffer plus β-adrenergic receptor
stimulation with isoprenaline hydrochloride (ISO; 10 nM);
and (v) unpaced, crystalloid perfusion with stepwise
logarithmic increases in ISO concentration (from 0.01 to
1000 nM). Sodium L-ascorbate (0.05 mM) was added to
both the vehicle and ISO-containing buffer to prevent
catecholamine oxidation. In group (iv), hearts were
initially perfused with the vehicle buffer (containing
ascorbate alone) for a 20 min functional equilibration and
paced at 350 beats min−1 before switching to the ISO
buffer. In these hearts, higher baseline pacing rates were
used to account for the positive chronotropic effect of
ISO. Hearts were perfused with the KHmetab buffer + ISO
for a further 10 min equilibration to allow the function
to stabilize before the pacing protocol was initiated and
effluent samples were collected as described above.
31P Magnetic resonance spectroscopy (MRS)
31P Magnetic resonance spectroscopy experiments were
conducted in a vertical-bore Bruker Avance III 400 MHz
wide-bore spectrometer (Bruker Biospin, Switzerland)
with triple axis gradients, a microimaging probe and an
exchangeable 15 mm 1H/31P dual tune birdcage coil (m2m
C© 2015 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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Imaging, Cleveland, OH, USA). Following cannulation
on a specially constructed, MR-compatible umbilical
perfusion rig, the rat heart was lowered into the centre
of the magnet at the position previously verified as
the isocentre of the coil. Temperature calibration was
performed in situ using a capillary containing ethylene
glycol at the position of the heart. Shimming was carried
out on the 1H signal of water, which was <50 Hz. Fully
relaxed 31P spectra were acquired with an experiment
duration of 13 min, 200 scans, repetition time of 3.85 s,
a 90 deg flip angle, 9.8 kHz sweep width and acquisition
data size of 16,384 points. After functional equilibration,
hearts were perfused with the KH buffer and paced for
10 min at 350 beats min−1 followed by 10 min perfusion at
500 beats min−1. All spectra were processed with 20 Hz line
broadening, and peak integrals were fitted using Bruker
Top Spin version 2.1 software.
Statistical analysis
The results are presented as means ± SEM. Statistical
significance of functional parameters was assessed using
GraphPad Prism 6 software (GraphPad Software Inc.,
La Jolla, CA, USA). Linear relationships were fitted by
least-squares analysis and correlation was assessed using
Pearson’s product–moment correlation coefficient (r).
Some relationships appeared to have two linear phases
either side of an inflection. In these cases, the whole
data range was fitted initially using the entire data set
and a single Pearson’s r value derived. Subsequently,
the two linear phases were then fitted separately with
the inflection arbitrarily defined. If either of these
two phases reported a higher r value than the whole
data range, then this double-fit is presented rather
than a single linear regression. Some data were best
described by a single exponential function according
to Y = (Y0 − Plateau) × exp(−K × X) + Plateau.
Differences between two means were analysed using
Student’s unpaired t test and considered significant when
P < 0.05.
Results
Rate–pressure product and cardiac function in the
KH-perfused heart
Figure 1A shows the relationship between LVDP and
heart rate. There was a negative linear relationship
between increasing heart rate and LVDP (a negative FFR).
Increasing the pacing rate from 300 to 750 beats min−1
resulted in a 79% decrease in LVDP from 103 to
21 mmHg and a fivefold increase in left ventricular
end-diastolic pressure from baseline levels (from 4.9 ± 1.7
to 33 ± 5.1 mmHg; not shown). The slope of this negative
LVDP–frequency relationship was −0.99 mmHg beat
min−1. In this pacing protocol, there was a gradual increase
in absolute coronary flow as heart rate increased (Fig.
1B). Interestingly, despite the gradual vasodilatation in
response to increasing heart rate, coronary flow expressed
per beat declined with increasing rate (Fig. 1B). Myocardial
oxygen consumption as a function of heart rate and RPP
are shown in Fig. 1C and D. Figure 1C shows that the
combination of an increase in heart rate and the associated
reduction in LVDP (Fig. 1A) results in no net change
in O2 consumption over a wide range in heart rates.
Hence, unlike the positive correlation originally described
by Katz & Feinberg (1958), it is clear that there was
absolutely no correlation between RPP and myocardial
oxygen consumption (r = 0.037; Fig. 1D). The numbers
next to the symbols in Fig. 1D indicate the heart rate
at each point. Interestingly, the absolute arteriovenous
oxygen difference remained largely constant and within a
narrow range [0.17–0.18 μmol (g dry wt)−1] at all pacing
frequencies (see Table S1). This is in accord with Laurent
et al. (1956), who concluded that net oxygen delivery to
the myocardium is primarily determined by the prevailing
coronary flow rather than any change in the efficiency of
arteriovenous extraction.
Impact of increasing heart rate on cardiac metabolism
One of the many limitations of the isolated KH
buffer-perfused heart is the lack of oxygen-carrying
capacity of the perfusate. At high heart rates, it is
possible that this may lead to a demand ischaemia.
Figure 2A, however, shows that, over the range of heart
rates tested, there was no net increase in myocardial
lactate production as might have been indicative of a
gradually developing demand ischaemia. Likewise, 31P
nucelar magnetic resonance spectra (Fig. 2C), ATP and
phosphocreatine (PCr) content, PCr/ATP ratios (Fig. 2B)
and intracellular pH were all unaffected by increasing
the heart rate from 350 to 500 beats min−1 (a heart rate
range equivalent to that measured in vivo in rats (Bolter &
Atkinson, 1988).
Provision of substrate-enriched metabolic buffer
Not only is the isolated heart potentially oxygen deficient at
high heart rates but it may also be substrate deficient, being
typically provided only with glucose (and no insulin) as
a metabolic substrate. In order to investigate whether this
impacts upon metabolic efficiency and the relationship
between RPP and oxygen consumption, the protocols in
Fig. 1 were repeated with a substrate-enriched metabolic
buffer (KHmetab). Figure 3A shows that, as in KH buffer,
the LVDP–frequency relationship remained negative
(slope −0.98 mmHg beat min−1). In contrast, however,
baseline coronary flow was reduced at 325 beats min−1
in KHmetab buffer to 7.1 ± 0.6 ml min−1 (cf.
C© 2015 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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12.3 ± 0.7 ml min−1 in KH buffer at 350 beats min−1;
Fig. 3B). With increasing heart rate, absolute coronary flow
(in millilitres per minute) remained relatively constant
over the range 325–650 beats min−1, declining slightly
over the entire frequency range (r = −0.88). As in KH
perfusion, coronary flow per beat declined with increasing
frequency (Fig. 3B). The relationship between heart rate
and absolute coronary flow was mirrored by a similar
profile of oxygen consumption (Fig. 3C). In these hearts,
at baseline (325 beats min−1) the MV̇O2 was significantly
lower in KHmetab-perfused hearts compared with
KH-perfused hearts [MV̇O2 in KHmetab = 0.93 ± 0.1 versus
2.27 ± 0.2 μmol O2 min−1 (g dry weight)−1 in KH;
P < 0.05]. In addition, there is some indication that
the relationship between heart rate and MV̇O2 shows two
phases; below 525 beats min−1 MV̇O2 appears independent
of heart rate, whereas above 525 beats min−1 MV̇O2
declines gradually as heart rate increases (Fig. 3C).
The KHmetab-perfused hearts showed an apparent
positive correlation between RPP and myocardial oxygen
consumption (Fig. 3D), again showing some evidence of
a two-phase response. However, closer inspection reveals
that this RPP–MV̇O2 relationship is, in fact, ‘upside-down’;
that is, as both LVDP and MV̇O2 decline with increasing
heart rate, high rates are associated with a low RPP
and a low MV̇O2 and, conversely, low heart rates with



































































































RPP (mmHg.beats min−1 x 103)
Figure 1. Myocardial oxygen consumption (MV̇O2 ), left ventricular developed pressure (LVDP) and
coronary flow plotted as a function of heart rate or rate–pressure product (RPP) in crystalloid
Krebs–Henseleit (KH) buffer perfusions
Relationship between pacing rate and LVDP (A) and coronary flow (B). Myocardial oxygen consumption
is plotted as a function of heart rate (C) or RPP (D). Data are means ± SEM (n = 8). The r value is the
Pearson correlation for each linear relationship. Non-linear fits are as described in the Methods.
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a high RPP and high MV̇O2 . Figure 3E shows the
relationship between heart rate and lactate production.
This relationship again shows two phases, again with an
inflection at 525 beats min−1, above which increases in
heart rate appear to be linearly associated with increased
lactate production.
Effects of β-adrenoceptor stimulation on RPP and
MV̇O2
Figure 4A shows that, although ISO (10 nM) had the
expected positive inotropic effect at all heart rates,
the LVDP–frequency relationship remained negative
(−0.97 mmHg beat min−1) (see also Fig. S1). Isoprenaline
at baseline (400 beats min−1) caused a 52% increase in
coronary flow (18.7 ± 1.8 ml min−1) compared with
KH alone (12.3 ± 0.7 ml min−1). Further increase in
heart rate in the presence of ISO caused very little
change in absolute coronary flow and, as previously
observed, a substantial decline in flow per beat (Fig. 4B).
These changes in coronary perfusion were accompanied
by increased oxygen demand (Fig. 4C; r = 0.97).
The relationship between RPP and MV̇O2 is shown in
Fig. 4D. This relationship, which was absent in KH
buffer alone (Fig. 1C), was transformed into a significant
negative correlation by β-adrenoceptor stimulation. This
appears to be associated with a gradually developing
demand-induced ischaemia (Fig. 4B) as indicated by a
significant increase in lactate production (Fig. 4E).
Figure 5 shows the data from hearts perfused
with KHmetab buffer in the presence of β-adrenergic
stimulation. In contrast to the KHmetab buffer results in
the absence of ISO (Fig. 3B), as heart rate increased so
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Figure 2. Metabolic profile of crystalloid KH buffer-perfused hearts
A, lactate production measured in coronary effluent at each pacing rate (n = 8). B, comparison of
PCr/ATP ratios at physiological heart rates 350 (baseline) and 500 beats min−1 (n = 4). C, representative
in situ perfused and paced heart 31P spectra. Abbreviations: ATP, adenosine triphosphate; and PCr,
phosphocreatine. Averaged data are means ± SEM.
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RPP (mmHg.beats min−1 x 103)
Figure 3. Myocardial oxygen consumption, LVDP, coronary flow and lactate production plotted as a
function of heart rate or RPP in buffer supplemented with metabolic substrates (KHmetab)
Relationship between pacing rate and LVDP (A) and coronary flow (B). Myocardial oxygen consumption
is plotted as a function of heart rate (C) or RPP (D). The lactate production measured in coronary effluent
at each pacing rate is shown in E. Data are means ± SEM (n = 9). The r value is the Pearson correlation
for each linear relationship, and inflections and regions of linear fit were defined as described in the
Methods section.
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Figure 4. Effect of isoprenaline (ISO; 10 nm) on MV̇O2 , LVDP, coronary flow and lactate production
plotted as a function of heart rate or RPP in hearts perfused with KH buffer
Relationship between pacing rate and LVDP (A) and coronary flow (B). Myocardial oxygen consumption
is plotted as a function of heart rate (C) or RPP (D). The lactate production measured in coronary effluent
at each pacing rate is shown in E. Data are means ± SEM (n = 5). The r value is the Pearson correlation
for each linear relationship. Non-linear fits are as described in the Methods.
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Figure 5. Effect of ISO (10 nm) on MV̇O2 , LVDP, coronary flow and lactate production plotted as a function
of heart rate or RPP in hearts perfused with KHmetab buffer
Relationship between pacing rate and LVDP (A) and coronary flow (B). Myocardial oxygen consumption
is plotted as a function of heart rate (C) or RPP (D). The lactate production measured in coronary effluent
at each pacing rate is shown in E. Data are means ± SEM (n = 5). The r value is the Pearson correlation
for each linear relationship. Non-linear fits are as described in the Methods.
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did coronary flow (Fig. 4B). This increase in coronary
flow resulted in increased oxygen extraction and increased
oxygen consumption (Fig. 5C). The relationship between
RPP and MV̇O2 is shown in Fig. 5D. This relationship,
which was ‘upside-down’ in KHmetab buffer (Fig. 3D),
was transformed into a significant positive correlation
by ISO stimulation (Fig. 5D). Coronary vasodilatation
caused by ISO resulted in reduced lactate production
(Fig. 5E).
Effect of ISO-mediated increase in heart rate on the
RPP–MV̇O2 relationship
Given that electrical pacing is not the usual mechanism for
increasing rate in vivo (even in the presence of low-dose
β-receptor stimulation, as was done in Figs 4 and 5), in
these experiments rate was increased in unpaced hearts
by constructing a cumulative ISO dose–response curve.
Figure 6A shows the relationship between LVDP and heart
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Figure 6. The effect of changing heart rate with increasing concentrations of ISO on LVDP, coronary
flow, oxygen consumption and lactate production
Hearts were unpaced, and ISO concentration was increased stepwise every 10 min. The ISO concentrations
used were 0.01, 0.1, 1, 10, 100 and 1000 nM. Relationship between heart rate and LVDP, A and coronary
flow, B. Myocardial oxygen consumption is plotted as a function of heart rate, C or RPP, D. The lactate
production measured in coronary effluent at each ISO concentration is shown in E. Data are means ± SEM
(n = 5). The r value is the Pearson correlation for each linear relationship. Non-linear fits are as described
in the Methods.
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rate at various concentrations of ISO. Even in the presence
of increasing ISO concentrations, the force–frequency
response remained negative. At lower ISO concentrations
(heart rates), absolute coronary flow and flow per beat
were substantially higher than in the absence of ISO but
similar to that in 10 nM ISO (Fig. 6B). As heart rate was
increased (with increasing ISO concentrations), absolute
coronary flow remained relatively constant, whereas flow
per beat declined. Oxygen consumption also declined as
heart rate increased (Fig. 6C). Again, as in the KH buffer,
for KH buffer+ ISO, there was no correlation between RPP
and MV̇O2 (Fig. 6D) and no increase in lactate production
(Fig. 6E).
Discussion
This study demonstrates that, despite its widespread use,
RPP is an unreliable index of MV̇O2 or cardiac ‘effort’.
Although the provision of substrates or β-adrenergic
stimulation changed the shape of the RPP–MV̇O2 relation-
ship, neither intervention resulted in a clear positive
correlation between RPP and oxygen consumption. In KH
buffer alone, although MV̇O2 increased with heart rate,
LVDP declined. Hence, the product of HR × pressure
(RPP) remained flat.
In isolated papillary muscle or trabecular preparations,
the FFR is often studied at relatively unphysiological low
rates of electrical stimulation, high Ca2+ concentrations,
in the absence of catecholamines or vagal tone and, not
infrequently, at room temperature (for review, see Bers,
2000). In these conditions, the FFR is clearly species
dependent and has a positive slope in guinea-pig, rabbit,
dog and human cardiac muscle and is flat or negative
in rat and mouse cardiac muscle (Schouten & ter Keurs,
1986; Redel et al. 2002). In most species, the increase
in inotropy with increasing rate reflects an increase in
the time-averaged Ca2+ influx, a decrease in the diastolic
interval available for Ca2+ extrusion, a rise in intracellular
Na+, and a consequent rise in sarcoplasmic reticulum (SR)
Ca2+ load and fractional Ca2+ release (for review, see Bers,
2000). In rat and mouse cardiac muscle at low rates of
stimulation, the SR is relatively Ca2+ loaded, intracellular
Na+ is already elevated, and rate increases may even unload
the SR of Ca2+. This, combined with the refractoriness of
the SR Ca2+ release process, may account for the negative
inotropy on increasing stimulation rates in these species
(Bers, 2000).
In isolated muscles, the failure to study the FFR at
higher rates of stimulation and at 37°C is, in part, driven
by concerns about the adequacy of oxygen and substrate
delivery in these superfused preparations (Schouten &
ter Keurs, 1986). Although it seems unlikely that muscle
bundles of similar sizes from species with a positive FFR
are somehow better oxygenated than those from rats,
concern remains that an element of the negative FFR
at high pacing rates may reflect inadequate oxygenation
and/or substrate delivery. Indeed, in a study by Layland
& Kentish (1999), when thin (80–250 μm) trabeculae
were perfused at 37°C in 1 mM Ca2+, the FFR remained
positive over the range 0–12 Hz. In subsequent studies,
Raman et al. (2006) also showed that smaller muscle
diameters (<150 μm) are correlated with improved
muscle performance, particularly at high pacing rates.
Whether these observations reflect the inadequacy of
diffusion to maintain viability of larger muscles or an
intrinsic difference in the cellular properties of smaller
muscles has not been determined.
In isolated hearts, as in isolated muscles, the developed
pressure–frequency relationship is typically positive (or
biphasic) in most larger species and is negative or flat
in rats or mice (Taylor & Cerny, 1976; Mattheussen
et al. 1996; Maier et al. 1997; Sutherland et al. 2003).
In the present study, although arterial perfusion might
improve oxygen delivery, it was important to rule out the
possibility that a negative FFR at higher pacing rates simply
reflects inadequate perfusion and demand ischaemia
(see (Kuzmiak-Glancy et al. 2015). Krebs–Henseleit
buffer-perfused hearts have very high coronary flows
(10–20 ml min−1 g−1) compared with those measured
in vivo or in blood-perfused hearts (1 ml min−1 g−1).
These high coronary flows may limit locally derived
vasoactive agents from achieving concentrations necessary
to cause appropriate or sufficient dilatation in response
to increases in heart rate. However, despite this, in
the present study, in normal KH-perfused hearts, the
PCr/ATP ratio was not reduced at higher pacing rates. This
suggests that the decline in LVDP was not attributable to
progressive demand ischaemia. In isolated hearts supplied
only with glucose and no insulin, it is also reasonable to
consider the possibility that demand ischaemia may also
be induced by inadequate substrate delivery as well as
inadequate O2 delivery. However, the lack of significant
frequency-dependent lactate production and the finding
that the provision of alternative substrates did not affect
the negative FFR, or indeed the RPP–MV̇O2 relationship,
suggests that substrate delivery is not the limiting factor
in this context.
In vivo, heart rate is never substantially elevated in the
absence of β-adrenoceptor occupation. Vagal withdrawal
may modulate heart rate, but substantial increases in rate
during exercise are always accompanied by sympathetic
outflow and β-adrenergic stimulation. On a cellular
level, β-adrenergic stimulation will phosphorylate key
proteins involved in excitation–contraction coupling,
such as L-type Ca2+ channels, ryanodine receptors,
phospholamban and phospholemman. These latter two
protein kinase A substrates may act in concert to limit
cytosolic Ca2+ and Na+ accumulation when heart rate
increases in vivo, but this effect may be absent when
isolated preparations are electrically paced in the absence
C© 2015 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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of β-adrenergic stimulation. This raises the question:
does the negative FFR in rats and mice ever occur in
vivo? In fact, it seems teleologically surprising that, in
a fight-or-flight situation, the contractility of the rat or
mouse heart would decline when heart rate goes up. The
answer to this question is beyond the scope of the present
study, but it is interesting to note that the negative FFR
of an isolated mouse heart could be transformed into
a positive FFR if heart rate was raised by β-adrenergic
stimulation rather than by electrical pacing (Kennington,
2009). In the present study (Fig. 6), the rat heart, unlike the
mouse heart, maintained a negative FFR even when heart
rate was raised by cumulative increases in isoprenaline
concentration, suggesting that the negative FFR of the rat
heart is not the result of a lack of β-adrenergic stimulation.
As discussed above, the lack of correlation between
RPP and MV̇O2 may simply be a limitation of ex
vivo perfusion and the inadequacies of oxygen delivery,
receptor stimulation or substrate provision, rather than
a species-specific phenomenon. We have been unable
to find studies in the literature relating these variables
in Langendorff-perfused hearts from other small animal
species (i.e. rabbit, guinea-pig etc.), in which the FFR is
reported to be positive. Likewise, no studies have measured
MV̇O2 and the FFR in vivo in rats or mice, although, as
discussed above, it would be teleologically surprising if
the negative FFR persists in vivo. It would be interesting to
repeat the present study not only in small animals in vivo
but also in KH-perfused rabbit hearts and hearts of both
species perfused with erythrocytes or perfluorocarbons to
improve O2 delivery.
When designing the present study, the assumption was
made that hearts perfused with the enhanced substrate
mix (KHmetab buffer) would be more stable and less
prone to demand ischaemia than glucose-fed hearts
(KH buffer). Surprisingly, this was not borne out by
the results. In KHmetab buffer, LVDP and coronary flow


































Figure 7. Relationship between oxygen consumption and
coronary flow for all hearts
Data are replotted from the data in Figs 1, 3, 4, 5 and 6. The
curve is an exponential fitted using the following equation:
Y = 0.342 × exp(0.1205X).
were consistently lower than in KH buffer and, on
increasing heart rate, KHmetab-perfused hearts produced
more lactate. The inclusion of BSA in the perfusion
solutions increased both the viscosity and the oncotic
pressure of these solutions. Whether it is a change in
viscosity or some effect on the tissue oedema (known to
accompany crystalloid perfusion), there is demonstrably
a reduction in coronary flow in hearts perfused with the
KHmetab buffer. If coronary flow is reduced for reasons of
viscosity and/or changes in oedema, then as the inclusion
of BSA does not alter or improve the oxygen-carrying
capacity, this may limit oxygen delivery and may explain
why these KHmetab-perfused hearts are more susceptible
to demand ischaemia.
Finally, it is interesting to note that in the
crystalloid-perfused rat heart it is coronary flow (i.e.
oxygen delivery) and not heart rate that is best correlated
with oxygen consumption. The correlation between
MV̇O2 and heart rate was poor across all protocols;
sometimes being positive, sometimes flat and sometimes
negative. In contrast, there was a good correlation in
all conditions studied between MV̇O2 and coronary flow
(oxygen delivery) (Fig. 7). The correlation between oxygen
delivery and oxygen consumption was positive, non-linear
and increased by β-adrenergic stimulation in all protocols.
This observation was made more than 50 years ago in an
elegant series of studies published in 1963 showing, in
non-working isolated heart preparations, that increasing
coronary flow increases oxygen consumption in isolated
non-working hearts when demand is constant (Kahler
et al. 1963). That is, under these conditions, it is delivery
of oxygen that determines MV̇O2 rather than the increase
in O2 consumption that drives changes in coronary flow.
In the present study, both contractility (i.e. demand) and
coronary flow (i.e. O2 delivery) change with changes in
pacing rate and hence while MV̇O2 and coronary flow
correlate, this correlation may be a undefined mixture
of cause and effect.
In conclusion, although many studies use RPP in the
isolated Langendorff-perfused rat heart, the negative FFR
in this preparation means that RPP is an unreliable index
of oxygen consumption or ‘cardiac effort’ and should be
avoided.
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Table S1: Absolute values of arterial and venous O2
content, A-V oxygen consumption and coronary flow at
different heart rates in KH perfused hearts. These data
were used to generate the relationships shown in Figure 1.
Date are mean ± SEM (n=8/group).
Figure S1: Comparison of the effects of isoprenaline (ISO)
on the relationship between pacing rate and left ventricular
developed pressure (LVDP) in hearts perfused with KH
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3A, 4A and 5A.
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